Cytokine-Mediated Alterations of Human Cardiac Fibroblast's Secretome

Fibroblasts contribute to approximately 20% of the non-cardiomyocytic cells in the heart. They play important roles in the myocardial adaption to stretch, inflammation, and other pathophysiological conditions. Fibroblasts are a major source of extracellular matrix (ECM) proteins whose production is regulated by cytokines, such as TNF-alpha or TGF-beta. The resulting myocardial fibrosis is a hallmark of pathological remodeling in dilated cardiomyopathy (DCM). Therefore, in the present study, the secretome and corresponding transcriptome of human cardiac fibroblasts from patients with DCM was investigated under normal conditions and after TNF-alpha or TGF-beta stimulation. Secreted proteins were quantified via mass spectrometry and expression of genes coding for secreted proteins was analyzed via Affymetrix Transcriptome Profiling. Thus, we provide comprehensive proteome and transcriptome data on the human cardiac fibroblast's secretome. In the secretome of quiescent fibroblasts, 58% of the protein amount belonged to the ECM fraction. Interestingly, cytokines were responsible for 5% of the total protein amount in the secretome and up to 10% in the corresponding transcriptome. Furthermore, cytokine gene expression and secretion were upregulated upon TNF-alpha stimulation, while collagen secretion levels were elevated after TGF-beta treatment. These results suggest that myocardial fibroblasts contribute to pro-fibrotic and to inflammatory processes in response to extracellular stimuli.

Automated summary

Fibroblasts are crucial in cardiac adaptation and pathological remodeling, with their secretome and transcriptome playing essential roles in myocardial fibrosis in diseases like dilated cardiomyopathy. Cytokines, such as TNF-alpha and TGF-beta, regulate the production of ECM proteins by fibroblasts, highlighting their involvement in pro-fibrotic and inflammatory processes in response to external stimuli.